Risk factors for severe Chlamydia pneumoniae pneumonia in children: a retrospective case–control study
Abstract
Objective This study aimed to investigate the clinical characteristics of Chlamydia pneumoniae pneumonia (CPP) in children and analyze the risk factors for progression to severe pneumonia. Methods A total of 133 children with CPP were retrospectively enrolled from Hebei Children's Hospital between 2023 and 2025. Disease severity was classified according to the Guidelines for the Management of Community-Acquired Pneumonia in Children (2024 revision), and patients were divided into a non-severe group (n = 99) and a severe group (n = 34). Demographic characteristics, clinical manifestations, and laboratory findings were compared between groups. Multivariate binary logistic regression analysis was performed to identify independent factors associated with severe disease. Results Compared with the non-severe group, children in the severe group had a higher peak temperature and longer duration of fever (both P 0.05). Laboratory findings showed a lower lymphocyte percentage and higher levels of WBC, CRP, and IgA in the severe group (all P < 0.05). Multivariate analysis identified decreased lymphocyte percentage (OR = 0.943, 95% CI 0.895–0.994) and elevated IgA (OR = 2.227, 95% CI 1.284–3.972) as factors associated with severe CPP. Conclusion Decreased lymphocyte percentage and elevated serum IgA are associated with severe CPP in children, suggesting potential roles in risk stratification. Further multicenter prospective studies are warranted to validate and confirm these findings.
Read the paper
Related studies
- Severe clinical outcomes of COVID-19 associated with proton pump inhibitors: a nationwide cohort study with propensity score matching
- Levofloxacin-Induced Tendon Rupture: A Case Report and Review of the Literature
- Association between cord blood 25-hydroxyvitamin D concentrations and respiratory tract infections in the first 6 months of age in a Korean population: a birth cohort study (COCOA)
- Neuroprotective Effects of Epicatechin against Oxidative Stress-Induced Cognitive Impairment: A Systematic Review and Meta-Analysis
- Quality evaluation and in vitro interaction studies between levofloxacin 250mg and diclofenac sodium 50mg tablets
- Molecular Epidemiology of mcr-1 -Positive Polymyxin B-Resistant Escherichia coli Producing Extended-Spectrum β-Lactamase (ESBL) in a Tertiary Hospital in Shandong, China
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.